Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission: Better Outcome Following Busulfan and Melphalan Compared to Busulfan and Cyclophosphamide : A Retrospective Study from the Acute Leukemia Working Party of the EBMT

Gorin, Norbert ClaudeLabopin, MyriamCzerw, TomaszLeibundgut, KurtBlaise, DidierDumas, Pierre YvesNemet, DamirArcese, WilliamFoa, RobertoWu DepeiHuynh, AnneZuckerman, TsilaMeijer, EllenCagirgan, SeckinCornelissen, JanMohty, MohamedNagler, Arnon2019-10-272019-10-2720150006-49711528-0020https://hdl.handle.net/11454/5166757th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FLeninfo:eu-repo/semantics/closedAccessAutologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission: Better Outcome Following Busulfan and Melphalan Compared to Busulfan and Cyclophosphamide : A Retrospective Study from the Acute Leukemia Working Party of the EBMTConference Object12623WOS:000368019003050Q1